Examkin

Soru

Zorluk: OrtaInterpreting Laboratory Results

A 58-year-old male presents to the clinic for routine follow-up. He has a 10-year history of type 2 diabetes mellitus and hypertension. Current medications include glipizide, amlodipine, and a recently initiated angiotensin-receptor blocker (valsartan). He reports feeling generally fatigued but denies any recent illness, nausea, vomiting, or diarrhea. Vital signs are within normal limits.

Laboratory results are as follows:

Serum ChemistryResultReference Range
Sodium139139 mEq/L136−145136-145 mEq/L
Potassium5.65.6 mEq/L3.5−5.03.5-5.0 mEq/L
Chloride112112 mEq/L98−10698-106 mEq/L
Bicarbonate1818 mEq/L22−2822-28 mEq/L
Blood urea nitrogen2626 mg/dL8−208-20 mg/dL
Creatinine1.51.5 mg/dL0.7−1.30.7-1.3 mg/dL
Glucose (fasting)158158 mg/dL70−11070-110 mg/dL
Urine StudiesResultReference Range
pH5.55.54.5−8.04.5-8.0
Sodium3535 mEq/LVariable
Potassium2020 mEq/LVariable
Chloride3030 mEq/LVariable

Based on the interpretation of these laboratory findings, which of the following is the most likely mechanism underlying this patient's acid-base disturbance?

  1. Impaired renal ammoniagenesis due to hypoaldosteronismCevap
  2. B
    Defective hydrogen ion secretion in the distal tubule
  3. C
    Excessive gastrointestinal loss of bicarbonate
  4. D
    Accumulation of unmeasured endogenous organic acids
  5. E
    Impaired bicarbonate reabsorption in the proximal tubule

Cevap

Impaired renal ammoniagenesis due to hypoaldosteronism
The correct answer accurately describes the pathophysiology of Type 4 Renal Tubular Acidosis (RTA). The patient has a normal anion gap metabolic acidosis (SAG = 139−(112+18)=9139 - (112 + 18) = 9 mEq/L). In this setting, the urine anion gap helps determine the source. A positive urine anion gap (UAG = (35+20)−30=+25(35 + 20) - 30 = +25 mEq/L) indicates impaired renal excretion of ammonium (NH4+NH_4^+). When combined with hyperkalemia in a patient with diabetes and recent ARB initiation, this confirms Type 4 RTA. Hypoaldosteronism causes potassium retention; the resulting hyperkalemia creates intracellular alkalosis in the proximal tubule, which suppresses glutaminase activity and thereby impairs renal ammoniagenesis.

Adım Adım Çözüm

1
Calculate the serum anion gap (SAG) to characterize the metabolic acidosis.
SAG = Na+−(Cl−+HCO3−)Na^+ - (Cl^- + HCO_3^-) = 139−(112+18)=9139 - (112 + 18) = 9 mEq/L.
A normal SAG (typically 8−128-12 mEq/L) confirms a non-anion gap metabolic acidosis (NAGMA), narrowing the differential to renal tubular acidoses (RTAs) or gastrointestinal bicarbonate losses.
2
Calculate the urine anion gap (UAG) to distinguish between renal and extrarenal causes of NAGMA.
UAG = (Na++K+)−Cl−(Na^+ + K^+) - Cl^- = (35+20)−30=+25(35 + 20) - 30 = +25 mEq/L.
A positive UAG indicates a failure of the kidneys to excrete adequate amounts of unmeasured NH4+NH_4^+ (ammonium), pointing to a renal defect (RTA) rather than gastrointestinal bicarbonate wasting.
3
Evaluate the serum potassium level and contextual clinical clues.
Potassium is elevated at 5.65.6 mEq/L. The patient has diabetes and is taking an angiotensin-receptor blocker (valsartan).
The combination of NAGMA, a positive UAG, and hyperkalemia defines Type 4 RTA. The hyperkalemia, caused by hypoaldosteronism (due to diabetic nephropathy and valsartan use), impairs proximal tubular ammoniagenesis, leading to the positive UAG and acidosis.

Anahtar Kavram

Type 4 Renal Tubular Acidosis presents as a normal anion gap metabolic acidosis with hyperkalemia and a positive urine anion gap, commonly seen in patients with diabetic nephropathy or those taking medications that interfere with the renin-angiotensin-aldosterone system.
Bu soruyu puanla

Konular

Interpreting Laboratory Results

Bu konudan daha fazla soru